Trial Profile
A multicenter, randomized, active-controlled study to assess the safety, tolerability, and efficacy of FTY720 in patients with acute, non-infectious intermediate, posterior and pan uveitis.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2014
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Intermediate uveitis; Panuveitis; Posterior uveitis
- Focus Therapeutic Use
- 25 Jan 2014 New trial record